Related Experiment Video
Updated: Aug 31, 2025
07:22
Optical Detection of E. coli Bacteria by Mesoporous Silicon Biosensors
Published on: November 20, 2013
17.0K
High-porosity hybrid bilayer-enabled portable LED plasmonic biosensing
Wen-Yin Ko1, Shin-Chwen Yeh1, Hsiao-Wen Chu1
1Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan. kjlin@nchu.edu.tw.
Chemical Communications (Cambridge, England)
|August 22, 2022
Summary
A novel hybrid nanomaterial enables efficient light absorption and photocurrent generation. This technology facilitates non-destructive detection of alpha-fetoprotein in blood, showing promise for point-of-care diagnostics.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Titanium dioxide (TiO2) and gold (Au) nanoparticles are widely studied for their unique optical and electronic properties.
- Plasmonic metasurfaces offer enhanced light-matter interactions.
- Efficient detection of biomarkers like alpha-fetoprotein is crucial for early disease diagnosis.
Purpose of the Study:
- To develop a TiO2-nanowire/Au-nanoparticle hybrid layer with enhanced visible light absorbance.
- To utilize this hybrid layer for a non-destructive, quantitative detection of alpha-fetoprotein.
- To assess the potential of this system for point-of-care testing applications.
Main Methods:
- Fabrication of a hybrid TiO2-nanowire/Au-nanoparticle layer with nanocavities and a plasmonic metasurface.
- Assembly of a blood-glucose strip-like testing protocol.
- Detection of alpha-fetoprotein in human serum using visible LED illumination.
Main Results:
- The hybrid layer demonstrated complete visible region absorbance.
- Remarkable photocurrent-extraction efficiency was achieved.
- Non-destructive quantitative detection of alpha-fetoprotein was successfully performed.
Conclusions:
- The TiO2-nanowire/Au-nanoparticle hybrid layer effectively utilizes light for efficient photocurrent generation.
- The developed testing protocol enables sensitive and specific alpha-fetoprotein detection.
- This technology holds significant potential for developing commercial point-of-care diagnostic devices.
